Back to search
FDAFDA · Food and drugs·Recall number D-1388-2020

Proparacaine Hydrochloride Ophthalmic Solution, USP, 0.5%, 15 mL per dropper bottle, Sterile, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-263-12

Published July 22, 2020 · Recall initiated: December 26, 2019

Summary

FDA records drug Class III recall D-1388-2020, published July 22, 2020 and initiated December 26, 2019. Recalling firm: Akorn, Inc.; Status: Terminated; Reported quantity: 33,343 bottles; Lot: Lot 9E52A, exp 04/2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Chemical contamination; out of specification results obtained for equipment cleaning residue rinse sample

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Akorn, Inc.
Distributor
Nationwide USA and Puerto Rico
Lot
Lot 9E52A, exp 04/2021
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Proparacaine Hydrochloride Ophthalmic Solution, USP, 0.5%, 15 mL per dropper bottle, Sterile, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC 17478-263-12 recalled?

Yes. FDA published recall D-1388-2020 on July 22, 2020. Reported hazard: Chemical contamination; out of specification results obtained for equipment cleaning residue rinse sample

What should I do if I have this product?

Voluntary: Firm initiated · Letter